RCEL is expected to report earnings to fall 13.03% to -30 cents per share on August 06
Q2'26
Est.
$-0.30
Q1'26
Missed
by $0.06
Q4'25
Est.
$-0.38
Q3'25
Missed
by $0.20
Q2'25
Missed
by $0.13
The last earnings report on May 14 showed earnings per share of -34 cents, missing the estimate of -28 cents. With 100.31K shares outstanding, the current market capitalization sits at 155.73M.
A.I. Advisor
published General Information
General Information
a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments
A.I.dvisor tells us that RCEL and MBOT have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RCEL and MBOT's prices will move in lockstep.
RCEL sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for RCEL moved above the 200-day moving average on July 02, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 26, 2026. You may want to consider a long position or call options on RCEL as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for RCEL just turned positive on June 29, 2026. Looking at past instances where RCEL's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
RCEL moved above its 50-day moving average on July 01, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for RCEL crossed bearishly below the 50-day moving average on June 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
RCEL broke above its upper Bollinger Band on July 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for RCEL entered a downward trend on June 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RCEL's P/B Ratio (54.054) is slightly higher than the industry average of (10.756). P/E Ratio (0.000) is within average values for comparable stocks, (61.593). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.713). RCEL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (1.612) is also within normal values, averaging (23.791).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Avita Medical (RCEL) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com
